CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 25 enrolled
Drug / intervention
Dronabinol 120mg/day +2 moredrug
Likely dose
Dronabinol 120mg/dayfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01394185
NCT01394185Phase 2Completed
CompareCT.gov

Effects of Dronabinol (Oral THC) on Cannabis Use

Johns Hopkins University·interventional·Posted Jul 14, 2011·Updated Aug 3, 2017

In Brief

A Phase 2 clinical trial evaluating Dronabinol 120mg/day, Placebo, and 1 other intervention for Marijuana Smoking. Completed, enrolled 25 participants across 1 site.

Detailed Summary

Study participants received dronabinol (0, 120mg/day and 240mg/day) for 12 consecutive days in a randomized order. During each dronabinol maintenance period they were able to self-administer active or placebo cannabis using either a progressive ratio schedule or choice between cannabis and monetary alternative.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMarijuana Smoking
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 14, 2011
Enrollment StartFeb 1, 2011
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 15.0 years ago

Interventions

Dronabinol 120mg/daydrug

Participants receive 40mg dronabinol 3 times daily

Placebodrug

Participants receive placebo

Dronabinol 240mg/daydrug

Participants receive 80mg dronabinol 3 times daily